These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12489680)

  • 21. Navigator: tools for informal structure-activity relationship discovery.
    Chapman D; Harris N; Park J; Critchlow RE
    J Mol Graph; 1995 Aug; 13(4):242-9. PubMed ID: 8527416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: mining for pharmacophores in phenotypic screens.
    Lushington GH
    Comb Chem High Throughput Screen; 2014; 17(8):651. PubMed ID: 25268543
    [No Abstract]   [Full Text] [Related]  

  • 23. [The Beilstein CrossFire Information System and its use in pharmaceutical chemistry].
    Vanco J
    Ceska Slov Farm; 2003 Mar; 52(2):68-72. PubMed ID: 12754926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico drug exploration and discovery using DrugBank.
    Wishart DS
    Curr Protoc Bioinformatics; 2007 Jun; Chapter 14():Unit 14.4. PubMed ID: 18428789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The biochemical basis of pharmaceutical chemistry. 9. The effect of structure on biopharmaceutic/pharmacokinetic behavior].
    Nuhn P; Neubert R
    Pharmazie; 1991 Jan; 46(1):61-72. PubMed ID: 1857735
    [No Abstract]   [Full Text] [Related]  

  • 26. Relational database design: evaluation of the recognition, isolation and treatment of hospitalized patients with tuberculosis.
    Robinson EN; Beard D
    Proc Annu Symp Comput Appl Med Care; 1994; ():999. PubMed ID: 7950104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cheminformatics--decision making in drug discovery.
    Lahana R
    Drug Discov Today; 2002 Sep; 7(17):898-900. PubMed ID: 12546931
    [No Abstract]   [Full Text] [Related]  

  • 29. Managing, profiling and analyzing a library of 2.6 million compounds gathered from 32 chemical providers.
    Monge A; Arrault A; Marot C; Morin-Allory L
    Mol Divers; 2006 Aug; 10(3):389-403. PubMed ID: 17031540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-binding databases.
    Timmers LF; Pauli I; Caceres RA; de Azevedo WF
    Curr Drug Targets; 2008 Dec; 9(12):1092-9. PubMed ID: 19128220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basic overview of chemoinformatics.
    Engel T
    J Chem Inf Model; 2006; 46(6):2267-77. PubMed ID: 17125169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to decide which are the most pertinent overly-represented features during gene set enrichment analysis.
    Barriot R; Sherman DJ; Dutour I
    BMC Bioinformatics; 2007 Sep; 8():332. PubMed ID: 17848190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can we accelerate medicinal chemistry by augmenting the chemist with Big Data and artificial intelligence?
    Griffen EJ; Dossetter AG; Leach AG; Montague S
    Drug Discov Today; 2018 Jul; 23(7):1373-1384. PubMed ID: 29577971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dark side of pharmaceutical chemistry.
    Westwell AD; Caldicott DG; Hutchings A
    Future Med Chem; 2012 Feb; 4(2):129-32. PubMed ID: 22300092
    [No Abstract]   [Full Text] [Related]  

  • 35. A biocurator perspective: annotation at the Research Collaboratory for Structural Bioinformatics Protein Data Bank.
    Burkhardt K; Schneider B; Ory J
    PLoS Comput Biol; 2006 Oct; 2(10):e99. PubMed ID: 17069453
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemical substructures in drug discovery.
    Merlot C; Domine D; Cleva C; Church DJ
    Drug Discov Today; 2003 Jul; 8(13):594-602. PubMed ID: 12850335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity in medicinal chemistry space.
    Gorse AD
    Curr Top Med Chem; 2006; 6(1):3-18. PubMed ID: 16454754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A; Lukin O; Demoiseaux R; Buzko A; Shivanyuk A
    J Chem Inf Model; 2010 Apr; 50(4):470-9. PubMed ID: 20297844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments of the chemistry development kit (CDK) - an open-source java library for chemo- and bioinformatics.
    Steinbeck C; Hoppe C; Kuhn S; Floris M; Guha R; Willighagen EL
    Curr Pharm Des; 2006; 12(17):2111-20. PubMed ID: 16796559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.